A single-chain-Fv-based immunofluorometric assay specific for the CEA variant NCA-2

Area of Science:

• Biochemistry
• Immunology
• Molecular Biology

Background:

• Carcinoembryonic antigen (CEA) is a protein belonging to the immunoglobulin gene superfamily.
• A C-terminal truncated form, NCA-2, is predominant in meconium and also found in cancer patient sera.
• Currently, no NCA-2-specific assay exists, limiting understanding of its clinical significance.

Purpose of the Study:

• To develop a specific assay for NCA-2 using phage display technology.
• To compare NCA-2 serum levels with CEA values in cancer patients.
• To investigate the potential clinical significance of NCA-2.

Main Methods:

• Construction of a phagemid library from mouse splenic mRNA immunized with purified NCA-2.
• Panning of the library to isolate NCA-2-specific single-chain variable fragments (scFv).
• Expression of soluble scFv, selection of a high-affinity clone, and development of an immunofluorometric assay.

Main Results:

• Isolation of several scFv clones with high specificity for NCA-2.
• Establishment of a sensitive (0.2 microg/l) immunofluorometric assay for NCA-2.
• The assay detected a distinct protein in serum with a lower molecular weight than CEA, and differences between routine CEA and CEA-specific assays correlated with NCA-2 values.

Conclusions:

• A novel, highly specific scFv-based assay for NCA-2 has been successfully developed.
• This assay enables the distinct measurement of NCA-2 in human serum.
• The findings pave the way for further investigation into the clinical relevance of NCA-2 in cancer.